Search for a clinical trial
Other search option(s)
7 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
CANADA
Ontario
TORONTO
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
St. Michael's Hospital
Keenan Research Centre
FRANCE
AUVERGNE-RHONE-ALPES
BRON
TEMPO : Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo (Phase II)
CHU de Lyon HCL - GH Est-Hôpital Louis Pradel
Service de génétique clinique
FRANCE
AUVERGNE-RHONE-ALPES
BRON
ALEGORI : Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (Phase II-III)
CHU de Lyon HCL - GH Est-Hôpital Louis Pradel
Service de génétique clinique
FRANCE
AUVERGNE-RHONE-ALPES
LYON
ELLIPSE : A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
Hospices Civils de Lyon
FRANCE
NORMANDIE
CAEN
EROSB : Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose (Phase I-II)
CHU de Caen - Hôpital de la Côte de Nacre
Service d'ORL et de Chirurgie Cervico-Faciale
ITALY
LOMBARDIA
PAVIA
Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (Phase II)- IT
Fondazione IRCCS Policlinico San Matteo
Clinica Medica III
SPAIN
Madrid
MADRID